John Cox Sigilon Therapeutics, Inc. (SGTX) insider trading activity

SGTX Quotes by TradingView

John Cox is of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 341 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John Cox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
341 Reduced 100.0%
0 Common Stock

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
CEO & President
JC

John Cox

Cambridge, MA

Track Institutional and Insider Activities on SGTX

Follow Sigilon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGTX shares.

Notify only if

Insider Trading

Get notified when an Sigilon Therapeutics, Inc. insider buys or sells SGTX shares.

Notify only if

News

Receive news related to Sigilon Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGTX